In Memory of Dr. Izabela Kuprys-Lipinska: A Pioneering Clinician, Scientist, and Beloved FriendALLERGYIF122024-12-110PRE
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhoodEUROPEAN RESPIRATORY JOURNALIF212024-10-300PRE
Usage prevalence of angioedema patient-reported outcome measures: Results from the UCARE and ACARE PROMUSE studyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62024-08-011OAAI
Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria Are Underused in Clinical Practice特应性皮炎和慢性荨麻疹患者报告的结局指标在临床实践中使用不足JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62024-06-013OAAI
Effect of an Intranasal Corticosteroid on Quality of Life and Local Microbiome in Young Children With Chronic Rhinosinusitis A Randomized Clinical TrialJAMA PEDIATRICSIF182023-04-0115OA
Late Breaking Abstract - The blood eosinophils count as a predictor of the response for omalizumab (OMA) in patients suffering from severe allergic asthmaEUROPEAN RESPIRATORY JOURNALIF212019-11-210PRE
Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary dataEUROPEAN RESPIRATORY JOURNALIF212019-11-210PRE
The effect of omalizumab on blood eosinophils count in patients with hypersensitivity to non-steroidal anti-inflammatory drugs (NSAID) compare to patients who tolerate NSAID-pilot studyEUROPEAN RESPIRATORY JOURNALIF212018-11-190PRE
Comparison of Omalizumab Therapy Effectiveness in Patients with Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Patients Who Tolerate NSAID (non-NSAID) - Polish Real Life ExperienceJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-010OAAI